2BB score and signals
Galectin Therapeutics Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 20 | Weak |
| Risk | 58 | Moderate |
Company facts
| Headquarters | Norcross, Georgia, United States |
| Founded | 2000 |
| Employees | 9 |
| 52-week range | $2.02 – $7.13 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-12 | — | -0.051 | — | $0.00 |
| 2026-08-17 | — | -0.0918 | — | $0.00 |
| 2026-05-15 | -0.08 | -0.0612 | $0.00 | $0.00 |
| 2026-03-31 | -0.08 | -0.102 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish